MDXHEALTH (MDXH) Stock Earnings & Estimates
NASDAQ:MDXH - BE0974461940 - Common Stock
3.53 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 37.05M 66.59% | 70.193M 89.45% | 90.049M 28.29% | 112.35M 24.77% | 137.3M 22.21% | 158.3M 15.29% | 222.71M 40.69% | |
| EBITDA YoY % growth | -32.95M -38.45% | -20.468M 37.88% | -16.683M 18.49% | 408K 102.45% | 15.122M 3,606.37% | 28.101M 85.83% | 39.854M 41.82% | |
| EBIT YoY % growth | -37.86M -41.06% | -27.327M 27.82% | -24.722M 9.53% | -9.678M 60.85% | 2.638M 127.26% | 11.424M 333.06% | 27.521M 140.91% | |
| Operating Margin | -102.19% | -38.93% | -27.45% | -8.61% | 1.92% | 7.22% | 12.36% | |
| EPS YoY % growth | -0.82 64.36% | -1.59 -94.65% | -1.27 20.13% | -0.51 59.64% | -0.29 43.78% | 0.05 117.70% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 72.46% | -0.09 37.34% | -0.09 51.68% | -0.07 52.40% | -0.06 44.44% | -0.03 65.12% |
| Revenue Q2Q % growth | 28.689M 23.04% | 31.567M 27.60% | 31.735M 30.64% | 33.91M 27.46% | 34.17M 19.10% | 38.25M 21.17% |
| EBITDA Q2Q % growth | 374.003K 252.03% | 1.36M 151.11% | 2.091M 189.32% | 3.315M 587.50% | 5.61M 1,399.99% | 10.71M 687.50% |
| EBIT Q2Q % growth | -2.117M 65.26% | -918K 91.42% | -765K 83.33% | 204K 106.35% | 1.173M 155.42% | 3.876M 522.22% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.15 64.29% | -0.13 | -0.02 | -18.60% |
| Q1 2025 Q2Q % growth | -0.19 38.71% | -0.13 | -0.06 | -43.29% |
| Q4 2024 Q2Q % growth | -0.14 64.10% | -0.20 | 0.06 | 28.51% |
| Q3 2024 Q2Q % growth | -0.40 | -0.28 | -0.12 | -45.24% |
| Q2 2024 Q2Q % growth | -0.42 -40.00% | -0.27 | -0.15 | -55.38% |
| Q1 2024 Q2Q % growth | -0.31 38.00% | -0.31 | 0.00 | -1.31% |
| Q4 2023 Q2Q % growth | -0.39 64.55% | -0.11 | -0.28 | -247.59% |
| Q3 2023 Q2Q % growth | -0.40 2.06% | -0.20 | -0.20 | -104.25% |
| Q2 2023 Q2Q % growth | -0.30 | -0.22 | -0.08 | -34.92% |
| Q1 2023 Q2Q % growth | -0.50 -22.42% | -0.33 | -0.17 | -52.00% |
| Q4 2022 Q2Q % growth | -1.10 | -0.67 | -0.43 | -65.07% |
| Q3 2022 Q2Q % growth | -0.41 | -5.41 | 5.00 | 92.45% |
| Q2 2020 Q2Q % growth | -1.80 | -1.63 | -0.17 | -10.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 26.605M 20.06% | 26.842M | -237K | -0.88% |
| Q1 2025 Q2Q % growth | 24.292M 22.48% | 24.551M | -259K | -1.05% |
| Q4 2024 Q2Q % growth | 24.739M 27.53% | 23.827M | 912K | 3.83% |
| Q3 2024 Q2Q % growth | 23.317M 20.50% | 21.91M | 1.407M | 6.42% |
| Q2 2024 Q2Q % growth | 22.159M 32.33% | 21.236M | 923K | 4.35% |
| Q1 2024 Q2Q % growth | 19.834M 34.93% | 18.574M | 1.26M | 6.78% |
| Q4 2023 Q2Q % growth | 19.398M -19.34% | 18.499M | 899K | 4.86% |
| Q3 2023 Q2Q % growth | 19.35M 73.48% | 18.354M | 996K | 5.43% |
| Q2 2023 Q2Q % growth | 16.745M 28.71% | 15.455M | 1.29M | 8.35% |
| Q1 2023 Q2Q % growth | 14.7M | 13.663M | 1.037M | 7.59% |
| Q4 2022 Q2Q % growth | 24.05M 108.95% | 12.58M | 11.47M | 91.18% |
| Q3 2022 Q2Q % growth | 11.154M | 9.761M | 1.393M | 14.27% |
| Q2 2022 Q2Q % growth | 13.01M 21.25% | % | ||
| Q4 2021 Q2Q % growth | 11.51M 34.15% | % | ||
| Q2 2021 Q2Q % growth | 10.73M 8.60% | % | ||
| Q4 2020 Q2Q % growth | 8.58M 842.86% | % | ||
| Q2 2020 Q2Q % growth | 9.88M -9.11% | 11.883M | -2.003M | -16.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1.64% | -5.57% | -2.2% |
| Revenue | 0% | -2.03% | 1.1% | 1.08% |